Chemoinformaics analysis of 13-Cyclopentyltridecanoic acid
| Molecular Weight | 282.468 | nRot | 13 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 6 |
| Exact Molecular Weight | 282.256 | nRing | 1 |
| Solubility: LogS | -5.741 | nHRing | 0 |
| Solubility: LogP | 7.151 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.335 |
| nHD | 1 | BPOL | 34.977 |
| QED | 0.424 |
| Synth | 1.875 |
| Natural Product Likeliness | 0.484 |
| NR-PPAR-gamma | 0.977 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.019 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -5.009 |
| MDCK | 0.0000253 |
| BBB | 0.022 |
| PPB | 0.987777 |
| VDSS | 0.759 |
| FU | 0.00625157 |
| CYP1A2-inh | 0.22 |
| CYP1A2-sub | 0.185 |
| CYP2c19-inh | 0.29 |
| CYP2c19-sub | 0.066 |
| CYP2c9-inh | 0.145 |
| CYP2c9-sub | 0.99 |
| CYP2d6-inh | 0.029 |
| CYP2d6-sub | 0.064 |
| CYP3a4-inh | 0.06 |
| CYP3a4-sub | 0.019 |
| CL | 2.304 |
| T12 | 0.412 |
| hERG | 0.054 |
| Ames | 0.005 |
| ROA | 0.01 |
| SkinSen | 0.932 |
| Carcinogencity | 0.054 |
| EI | 0.969 |
| Respiratory | 0.879 |
| NR-Aromatase | 0.075 |
| Antiviral | Yes |
| Prediction | 0.61754 |